Survival differences in European patients with AIDS, 1979–89

BMJ

Volumn 308, Issue 6936, 1994, Pages 1068-

  Lundgren, J D ^a,b,c,d   Pedersen, C ^a,b,c,d   Clumeck, N ^a,b,c,d   Gatell, J M ^a,b,c,d   Johnson, A M ^a,b,c,d   Ledergerber, B ^a,b,c,d   Vella, S ^a,b,c,d   Phillips, A ^a,b,c,d   Nielsen, J O ^a,b,c,d  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c Swiss HIV Cohort Study   (Switzerland)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; EUROPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; CD4-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; EUROPE; FEMALE; HUMAN; LEUKOCYTE COUNT; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; SURVIVAL ANALYSIS; TIME FACTORS; ZIDOVUDINE;

EID: 0028176775     PISSN: 09598138     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.308.6936.1068     Document Type: Article

References (19)

1. Pedersen C Gerstoft J Tauris P Lundgren JD Gotzsche PC Buhl M, et al. Trends in survival of Danish AIDS patients. AIDS 1990; 4: 1111–6.
2. Buira E Gatell JM Miro JM Bataala J Zamora L Mallolas J, et al. Influence of treatment with zidovudine (ZDV) on the long-term survival of AIDS patients. Journal of AIDS 1992; 5: 737–42.
3. Lemp GF Payne SF Neal D Temelso T Rutherford GW. Survival trends for patients with AIDS. JAMA 1990; 263: 402–6.
4. Moore RD Hidalgo J Sugland BW Chaisson RE. Zidovudine and the natural history of the acquired immunodeficiency syndrome. N Engl J Med 1991; 324: 1412–6.
5. Rothenberg R Woelfel M Stoneburner R Milberg J Parker R Truman B. Survival with the acquired immunodeficiency syndrome. N Engl J Med 1987; 317: 1297–302.
6. Harris JE. Improved short-term survival of AIDS patients initially diagnosed with Pneumocystis carinii pneumonia, 1984 through 1987. JAMA 1990; 263: 397–401.
7. Lemp GF Hirozawa AM Cohen JB Derish PA McKinney KC Hernandez SR. Survival for women and men with AIDS. J Infect Dis 1992; 166: 74–9.
8. Peters BS Beck EJ Coleman DG Wadsworth MJ McGuinness O Harris JR, et al. Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom: The changing face of AIDS. BMJ 1991; 302: 203–7.
9. Brenner F Ognibene FP Lack EE Simmons JT Suffredini AF Lane HC, et al. Prognostic factors and life expectancy of patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. Am Rev Respir Dis 1987; 136: 1199–206.
10. Centers for Disease Control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. MMWR 1989; 38(suppl 5):1–9.
11. National Institutes of Health-University of California Expert Panel for Corticosteroids as Adjunctive Therapy for Pneumocystis Pneumonia. Consensus statement on the use of corticosteroids as adjunctive therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 1990; 323: 1500–4.
12. Fischl MA Richman DD Grieco MH Gottlieb MS Volberding PA Laskin OL, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS related complex: a double-blind, placebo- controlled trial. N Engl J Med 1987; 317: 185–91.
13. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987; 36(suppl):3–15.
14. Vella S Guiliano M Pezzotti P Agresti MG Tomino C Floridin M, et al. Survival of zidovudine-treated patients with AIDS compared with that of contemporary untreated patients. JAMA 1992; 267: 1232–6.
15. Volberding PA Lagakos SW Kock MA Pettinelli C Myers MW Booth DK, et al. Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4- positive cells per cubic millimeter. N Engl F Med 1990; 322: 941–9.
16. Fischl MA Richman DD Hansen N Collier AC Carey JT Para MF, et al. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection: a double-blind, placebo-controlled trial. Ann Intern Med 1990; 112: 727–37.
17. Hamilton JD Hartigan PM Simberkoff MS Day PL Diamond GR Dickinson GM, et al. A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection: results of the veterans affairs cooperative study. N Engl J Med 1992; 326: 437–43.
18. Aboulker J-P Swart AM the Concorde Coordinating Committee. Preliminary analysis of the concorde trial. Lancet 1993; 341: 889–90.
19. Friedland GH Saltzman B Vileno J Freeman K Schrager LK Klein RS. Survival differences in patients with AIDS. Journal of AIDS 1991; 4: 144–53.